These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18328193)

  • 61. Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
    Kunitomi M; Takayama E; Suzuki S; Yasuda T; Tsutsui K; Nagaike K; Hiroi S; Tadakuma T
    Jpn J Cancer Res; 2000 Mar; 91(3):343-50. PubMed ID: 10760695
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.
    Zhang KJ; Zhang J; Wu YM; Qian J; Liu XJ; Yan LC; Zhou XM; Xiao RJ; Wang YG; Cao X; Wei N; Liu XR; Tang B; Jiao XY; Chen K; Liu XY
    Cancer Gene Ther; 2012 Sep; 19(9):619-29. PubMed ID: 22790965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
    Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F
    Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
    Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
    J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cationic
    Qu J; Wang W; Feng Y; Niu L; Li M; Yang J; Xie Y
    Int J Nanomedicine; 2019; 14():9745-9761. PubMed ID: 31849466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
    Guo ZS; Wang LH; Eisensmith RC; Woo SL
    Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.
    Park JH; Kim KI; Lee KC; Lee YJ; Lee TS; Chung WS; Lim SM; Kang JH
    Cancer Biother Radiopharm; 2015 Feb; 30(1):8-15. PubMed ID: 25545853
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4.
    Tian G; Yi JL; Xiong P
    World J Gastroenterol; 2004 Jan; 10(2):200-4. PubMed ID: 14716822
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Influence of staphylococcal enterotoxin A on immunogenicity of hepatocellular carcinoma cells].
    Li Z; Sui Y; Jiang Y; Lei Z
    Zhonghua Gan Zang Bing Za Zhi; 2001 Dec; 9(6):343-5. PubMed ID: 11782301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.
    Liu H; Wei Q; Wang J; Huang X; Li C; Zheng Q; Cao J; Jia Z
    BMC Cancer; 2015 Apr; 15():325. PubMed ID: 25924900
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
    Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Yun JP; Chak EC; Ho RL; Lai PB
    Int J Cancer; 2006 Oct; 119(8):1985-93. PubMed ID: 16708390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.
    Hou S; Kou G; Fan X; Wang H; Qian W; Zhang D; Li B; Dai J; Zhao J; Ma J; Li J; Lin B; Wu M; Guo Y
    Cancer Immunol Immunother; 2007 Oct; 56(10):1605-13. PubMed ID: 17361437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Hsieh YJ; Liu RS; Hwu L; Ke CC; Wang FH; Wang HE; Chen FD
    Anticancer Res; 2007; 27(3B):1571-9. PubMed ID: 17595778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
    Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
    Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.
    De la Rosa ÁJ; Rodríguez-Hernández Á; González R; Romero-Brufau S; Navarro-Villarán E; Barrera-Pulido L; Pereira S; Marín LM; López-Bernal F; Álamo JM; Gómez-Bravo MA; Padillo FJ; Muntané J
    Gene Ther; 2016 Jan; 23(1):67-77. PubMed ID: 26204498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recombinant plasmid pEGFP-AFP-TK delivered by nano-magnetic fluids targeting killed AFP positive HepG2 cells in vitro].
    Luo Y; Zhang YD; Peng J; Yan HX; Xue D; Wu K; Zhou L; Hang SW; Zhao JF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):437-9. PubMed ID: 19426602
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice.
    Ahmed CM; Wills KN; Sugarman BJ; Johnson DE; Ramachandra M; Nagabhushan TL; Howe JA
    J Interferon Cytokine Res; 2001 Jun; 21(6):399-408. PubMed ID: 11440637
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.